Olaparib effectively treats local recurrence of extrahepatic cholangiocarcinoma in a patient harboring a BRCA2-inactivating mutation: a case report

Cholangiocarcinoma (CCA) is a malignant tumor with poor prognosis and high recurrence rate. There is no standard treatment for advanced CCA beyond first-line chemotherapy, which provides only limited benefits. In this study, we report a case of a postoperative recurrence ECC patient harboring a brea...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenxin, Ma, Zuohong, Fu, Xibo, Hao, Zhiqiang, Shang, Hai, Shi, Junping, Lei, Mengping, Xu, Mian, Ning, Shili, Hua, Xiangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506765/
https://www.ncbi.nlm.nih.gov/pubmed/34734039
http://dx.doi.org/10.21037/atm-21-3681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506765/
https://www.ncbi.nlm.nih.gov/pubmed/34734039
http://dx.doi.org/10.21037/atm-21-3681

Ejemplares similares